跳至主要内容
临床试验/CTRI/2023/02/049970
CTRI/2023/02/049970招募中4 期

A Multicentric, Prospective, Observational, post Marketing surveillance study to evaluate safety of fixed dose combination of Vitamin C 1000mg + Zinc(in form of 32mg Zinc citrate trihydrate) 10mg effervescent tablet in clinical practice for treatment of Indian patients with vitamin C and zinc deficiency.

Kusum Healthcare Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1) Male and female with Age more than 18 year. 2)Vitamin C and zinc deficiency (based on independent clinical judgment of treating physician)3) Patients that requires treatment with Ascorbic acid and zinc tablets (as determined by treating physician) 4) Patients who provide informed consent

排除标准

  • 1) participation in another study 2) Presenting a risk of not being able to be followed. 3) Hypersensitivity to Ascorbic acid and zinc tablets

研究者

发起方
Kusum Healthcare Private Limited

相似试验